220 related articles for article (PubMed ID: 31694754)
1. Algorithm for antinuclear antibodies in subjects with clinical suspicion of autoimmune diseases.
Naranjo L; Shovman O; Pérez D; Infantino M; Cabrera-Marante O; Lozano F; Gilburd B; Manfredi M; Serrano M; Morillas L; Shoenfeld Y; Serrano A
Clin Exp Rheumatol; 2020; 38(4):633-639. PubMed ID: 31694754
[TBL] [Abstract][Full Text] [Related]
2. [Modern look at the problems of investigation of antinuclear antibodies in systemic lupus erythematosus (literature review).].
Aleksandrova EN; Verizhnikova ZG; Novikov AA; Lukina GV
Klin Lab Diagn; 2018; 63(6):340-348. PubMed ID: 30702224
[TBL] [Abstract][Full Text] [Related]
3. Antinuclear antibody titration and pattern are helpful in the diagnosis of systemic autoimmune rheumatic diseases.
Mohd Razi MS; Sugumaran Y; Mohd Haniz NA; Khilmie K; Osmera AH; Jauhary EJ; Wahab AA
Malays J Pathol; 2024 Apr; 46(1):63-69. PubMed ID: 38682845
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of screening methods for the determination of antinuclear antibodies using indirect immunofluorescence on HEp-2 cells and enzyme immunoassay in autoimmune liver diseases.
Dorofeev AS; Aleksandrova EN; Novikov AA; Saliev KG; Sandler YG; Vinnitskaya EV
Klin Lab Diagn; 2022 Nov; 67(11):652-657. PubMed ID: 36398774
[TBL] [Abstract][Full Text] [Related]
5. Second generation analysis of antinuclear antibody (ANA) by combination of screening and confirmatory testing.
Scholz J; Grossmann K; Knütter I; Hiemann R; Sowa M; Röber N; Rödiger S; Schierack P; Reinhold D; Bogdanos DP; Meroni PL; Radice A; Conrad K; Roggenbuck D
Clin Chem Lab Med; 2015 Nov; 53(12):1991-2002. PubMed ID: 26020561
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of antinuclear antibodies by indirect immunofluorescence and line immunoassay methods': four years' data from Turkey.
Sener AG; Afsar I; Demirci M
APMIS; 2014 Dec; 122(12):1167-70. PubMed ID: 24735346
[TBL] [Abstract][Full Text] [Related]
7. Clinical Aspects of the Dense Fine Speckled Pattern in Indirect Immunofluorescence-Antinuclear Antibody Screening and Its Association with DFS70 Autoantibodies.
La Jeon Y; Kang SY; Lee WI; Kim MH
Ann Clin Lab Sci; 2019 Sep; 49(4):496-502. PubMed ID: 31471339
[TBL] [Abstract][Full Text] [Related]
8. Identification of specific antinuclear antibodies in dogs using a line immunoassay and enzyme-linked immunosorbent assay.
Bremer HD; Lattwein E; Renneker S; Lilliehöök I; Rönnelid J; Hansson-Hamlin H
Vet Immunol Immunopathol; 2015 Dec; 168(3-4):233-41. PubMed ID: 26547884
[TBL] [Abstract][Full Text] [Related]
9. Negative ANA-IIF in SLE patients: what is beyond?
Abozaid HSM; Hefny HM; Abualfadl EM; Ismail MA; Noreldin AK; Eldin ANN; Goda AM; Ali AH
Clin Rheumatol; 2023 Jul; 42(7):1819-1826. PubMed ID: 37016193
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of systemic autoimmune rheumatic diseases and clinical significance of ANA profile: data from a tertiary hospital in Shanghai, China.
Yang Z; Ren Y; Liu D; Lin F; Liang Y
APMIS; 2016 Sep; 124(9):805-11. PubMed ID: 27328803
[TBL] [Abstract][Full Text] [Related]
11. The clinical relevance of anti-dsDNA antibodies determined by the Elia™ dsDNA assay in patients with negative indirect immunofluorescence on the HEp-2 cell.
Robier C; Haas M; Quehenberger F
Clin Chem Lab Med; 2021 Feb; 59(3):541-546. PubMed ID: 33064668
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic accuracy of ELISA methods as an alternative screening test to indirect immunofluorescence for the detection of antinuclear antibodies. Evaluation of five commercial kits.
Tonuttia E; Bassetti D; Piazza A; Visentini D; Poletto M; Bassetto F; Caciagli P; Villalta D; Tozzoli R; Bizzaro N
Autoimmunity; 2004 Mar; 37(2):171-6. PubMed ID: 15293886
[TBL] [Abstract][Full Text] [Related]
13. Comparison study of bead-based and line-blot multiplex ANA immunoassays in the diagnosis of systemic autoimmune rheumatic diseases.
Yuan W; Cao H; Li W; Wu X; Zheng J
Clin Rheumatol; 2022 Mar; 41(3):899-909. PubMed ID: 34626262
[TBL] [Abstract][Full Text] [Related]
14. Comparison of ANA testing by indirect immunofluorescence or solid-phase assays in a low pre-test probability population for systemic autoimmune disease: the Camargo Cohort.
Martinez-Revuelta D; Irure-Ventura J; López-Hoyos M; Olmos JM; Pariente E; Martín-Millán M; Nan D; Comins-Boo A; Martínez-Taboada VM; Hernández JL
Clin Chem Lab Med; 2023 May; 61(6):1095-1104. PubMed ID: 36634098
[TBL] [Abstract][Full Text] [Related]
15. [THE CLINICAL INFORMATIVENESS OF AUTOMATED METHODS OF SCREENING DETECTION OF ANTI-NUCLEAR ANTIBODIES USING INDIRECT REACTION OF IMMUNE FLUORESCENCE, ENZYME-LINKED IMMUNOSORBENT ASSAY AND MULTIPLEX XMAP TECHNOLOGY UNDER SYSTEMIC LUPUS ERYTHEMATOSUS].
Verizhnikova ZG; Aleksandrova EN; Novikov AA; Panafidina TA; Seredavkina NV; Popkova TV; Aizina NL; Nasonov EL
Klin Lab Diagn; 2017 Mar; 62(3):173-7. PubMed ID: 30620533
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the analytical and clinical performances of two different routine testing protocols for antinuclear antibody screening.
González Rodríguez C; Fuentes Cantero S; Pérez Pérez A; Vázquez Barbero FJ; León Justel A
J Clin Lab Anal; 2021 Sep; 35(9):e23914. PubMed ID: 34347308
[TBL] [Abstract][Full Text] [Related]
17. [Antinuclear antibodies in systemic autoimmune disease].
Rösken GHJ; van Beek AA; Bakker-Jonges LE; Schreurs MWJ
Ned Tijdschr Geneeskd; 2020 Apr; 164():. PubMed ID: 32324347
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the BioPlex 2200 ANA screen: analysis of 510 healthy subjects: incidence of natural/predictive autoantibodies.
Shovman O; Gilburd B; Barzilai O; Shinar E; Larida B; Zandman-Goddard G; Binder SR; Shoenfeld Y
Ann N Y Acad Sci; 2005 Jun; 1050():380-8. PubMed ID: 16014555
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of screening enzyme immunoassays compared to indirect immunofluorescence for anti-nuclear antibodies in patients with systemic rheumatic diseases: A systematic review and meta-analysis.
Jeong S; Yang D; Lee W; Kim GT; Kim HS; Ahn HS; Kim HJ
Semin Arthritis Rheum; 2018 Oct; 48(2):334-342. PubMed ID: 29609799
[TBL] [Abstract][Full Text] [Related]
20. Clinical value of anti-DFS70 antibodies in a cohort of patients undergoing routine antinuclear antibodies testing.
Yumuk Z; Demir M
J Immunol Methods; 2020 May; 480():112754. PubMed ID: 32057435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
